T. Y. Alvin Liu, M.D. is the James P. Gills, Jr. M.D., and Heather Gills Rising Professor of AI and the founding director of the Wilmer Precision Ophthalmology Center of Excellence. He is originally from Hong Kong, and speaks fluent Cantonese and Mandarin. He attended Phillips Exeter Academy in Exeter, New Hampshire, and graduated from Cornell University with a dual major in biology and economics. He received his M.D. from Columbia University in 2012, and completed his residency (2016) and fellowship (surgical and medical retina- 2018) at Johns Hopkins. He is subspecialty-trained in the medical and surgical treatment of vitreoretinal diseases, including age-related macular degeneration, diabetic retinopathy, diabetic macular edema, retinal vascular occlusion, retinal detachment, vitreous hemorrhage, epiretinal membrane and macular hole. Dr. Liu's research interests center on the application of artificial intelligence in the screening, diagnosis, prognostication and treatment of ophthalmic diseases, with a specific focus on vitreoretinal diseases such as age-related macular degeneration and diabetic retinopathy. In addition, he is involved in research on the pathogenesis of and treatment for pathologic myopia and the management of severe ocular trauma. Videos Dr. Tin Yan Alvin Liu Recent News Articles and Media Coverage AI Speeds Diabetic Retinopathy Diagnosis Without Specialist. Medscape August 28, 2018 AI Screening for Diabetic Retinopathy Moves to Retail Clinics. Medscape November 26, 2019 How Artificial Intelligence is Primed to Change Ophthalmology. Ophthalmology Advisor May 14, 2021 Medicine's first autonomous AI could prevent blindness due to diabetes. Stat News December 16, 2021 Innovations in Eye Care: How Technology is Transforming Ophthalmology. HealthTech November 29, 2022 Time to go multicultural. Retina Today March 1, 2023 How deep learning may play a role in predicting retinitis pigmentosa visual impairment. Ophthalmology Times March 14, 2023 AI in retinal diagnostics. Zhaoke Ophthalmology March 22, 2023 Macular Degeneration. Spotlight on Geographic Atrophy. Advances in Treatment. WebMD April 23, 2023 ARVO 2023: T.Y. Alvin Liu, MD discusses predictive AI and its application in ophthalmology. Modern Retina April 25, 2023 ASCRS: Prediction of imminent conversion to neovascular AMD using deep learning and 3D OCT volumes. OptometryTimes May 5, 2023 Adopting and regulating AI in healthcare. BNN Bloomberg May 29, 2023 AI could increase health equity and boost adherence to annual eye examination in patients with diabetes. Modern Retina June 21, 2023 As more Marylanders grow older, a debilitating eye disease is gaining ground. The Baltimore Banner June 26, 2023. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Usher Syndrome Type 2A, Cone Rod Dystrophy Amelogenesis Imperfecta, Cone-Rod Dystrophy, and Stargardt Macular Degeneration.

Dr. Couser obtained his bachelor’s degree from the University of Virginia and his Medical Doctorate from the Virginia Commonwealth University School of Medicine (VCU SOM). Dr. Couser’s ophthalmology residency was completed at Howard University where he served as co-chief resident in the last year of his residency. He received fellowship training in pediatric ophthalmology and adult strabismus at Emory University. Dr. Couser received a master’s degree in biotechnology from the Johns Hopkins University and completed a residency in clinical genetics at the University of North Carolina at Chapel Hill. He is one of only a few individuals currently board-certified by both the American Board of Ophthalmology and the American Board of Medical Genetics and Genomics. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/couser-cv Research Summary My primary research focus involves the identification and management of genetic eye diseases including rare inherited disorders affecting the eyes. Research and scholarly activities have been an integral component of my career path. I have been the principal investigator on 10 clinical trial/IRB studies and a co-investigator on others, participated with several committees or advisory panels related to research activities. I have been credited with over 120 book chapter, journal article and abstract publications. In addition, I served as the primary author/sole editor for a textbook titled Ophthalmic Genetic Diseases: A Quick Reference Guide to the Eye and External Ocular Adnexa Abnormalities, 1st Edition, published by Elsevier in 2018, which is one of only a few textbooks published in this subject area. I also served as a grant review panelist for the National Eye Institute Career Development Awards. Selected Publications *Couser NL, Masood MM, Strande NT, Foreman AKM, Crooks K, Weck KE, Lu M, Wilhelmsen KC, Roche M, Evans JP, Berg JS, Powell CM. 2015. The phenotype of multiple congenital anomalies- hypotonia-seizures syndrome 1: Report and review. Am J Med Genet Part A 9999A:1–6 *Couser NL, Lambert SR. Botulinum toxin: A treatment of consecutive esotropia in children. Strabismus 2012; 20(4):158-161 Couser NL, Lenhart PD, Hutchinson AK. Augmented Hummelsheim procedure to treat complete abducens nerve palsy. J AAPOS 2012;16(4):331-5 *Natario L. Couser, Maheer M. Masood, Arthur S. Aylsworth, and Roger E. Stevenson. Ocular manifestations in the X-linked intellectual disability syndromes. Ophthalmic Genet. 2017, Jan 23:1-12 *Couser NL, Brooks BP, Drack AV, Shankar SP. The evolving role of genetics in ophthalmology. Ophthalmic Genet. 2021 Jan 12:1-4. doi: 10.1080/13816810.2020.1868011. Dr. Couser is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Epicanthal Folds, Strabismus, Brown Syndrome, and Hypotonia.

Malin Howard is an Ophthalmologist in Columbia, Maryland. Dr. Howard is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Facial Paralysis, Recurrent Peripheral Facial Palsy, Bell's Palsy, and Cataract.

Parvathy Pillai is an Ophthalmologist in Columbia, Maryland. Dr. Pillai is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Cataract, Neuroretinitis, Glaucoma, and Uveitis. Dr. Pillai is currently accepting new patients.

Mariam Mathai is an Ophthalmologist in Columbia, Maryland. Dr. Mathai is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), and Vitrectomy. Dr. Mathai is currently accepting new patients.

Alan Malouf is an Ophthalmologist in Columbia, Maryland. Dr. Malouf is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Dry Eye Syndrome, Cataract, Glaucoma, and Allergic Conjunctivitis. Dr. Malouf is currently accepting new patients.

Olga Shif is an Ophthalmologist in Elkridge, Maryland. Dr. Shif is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Central Serous Chorioretinopathy, and Vitrectomy. Dr. Shif is currently accepting new patients.

Andrew Kundrat is a Geriatrics provider in Laurel, Maryland. Dr. Kundrat is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Muscle Atrophy, Vascular Dementia, Idiopathic Edema, and Necrosis.

Peter A. Campochiaro, M.D. is the George S. and Dolores Doré Eccles Professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins University School of Medicine. He is a clinician-scientist who directs a research laboratory and conducts clinical trials. His laboratory research is directed at understanding the pathogenesis of ocular neovascularization and excessive retinal vascular permeability, and the mechanism of cone cell death in inherited retinal degenerations. He helped to determine the importance of vascular endothelial growth factor (VEGF), hypoxia-inducible factor-1, and Tie2 in retinal and choroidal vascular diseases. The clinical trial group under Dr. Campochairo provided the first demonstration of the benefits of suppression of VEGF in diabetic macular edema and retinal vein occlusion. He has developed strategies for sustained suppression of VEGF that are currently being tested in clinical trials. Dr. Campochiaro trained at the University of Notre Dame, Johns Hopkins School of Medicine, and the University of Virginia. He did a vitreoretinal fellowship and research fellowships at Johns Hopkins and joined the faculty of the University of Virginia in 1984. He became professor of Ophthalmology and Neuroscience at the Wilmer Eye Institute, Johns Hopkins in 1991. Dr. Campochiaro is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Retinal Vein Occlusion, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Trabeculectomy, and Vitrectomy.

Marcie Wertlieb is an Ophthalmologist in Laurel, Maryland. Dr. Wertlieb is rated as an Advanced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Interstitial Keratitis, and Meibomianitis. Dr. Wertlieb is currently accepting new patients.

Dr. Susan Bressler is the Julia G. Levy, Ph.D. Professor of Ophthalmology at the Wilmer Eye Institute. She is an ophthalmologist and has subspecialty training in medical retinal disorders, vitreoretinal disease, and retinal surgery. Her main research interest has been collaborative efforts in clinical trials - serving as principal investigator of an image reading center that has served as a central unit for many clinical trials and epidemiologic investigations, as Vice Chair of the Diabetic Retinopathy Clinical Research Network and as principal investigator of a participating clinical center in several major clinical trials. Most studies have specific emphasis on the treatment of both non-neovascular and neovascular age-related macular degeneration and all aspects of diabetic retinopathy. Dr. Bressler has a large national and international referral practice. In addition, she has published 223 peer reviewed articles and 55 book chapters. Editorial Board positions have included American Journal of Ophthalmology, Survey of Ophthalmology, Retina, EyeNet Magazine, Health After 50: The Johns Hopkins Medical Letter and the Wilmer Retina Update. Dr. Bressler is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Diabetic Macular Edema (DME), Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, and Vitrectomy.

Fernando Arevalo is an Ophthalmologist in Baltimore, Maryland. Dr. Arevalo is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Gyrate Atrophy of the Choroid and Retina, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Diabetic Retinopathy.

Anuradha Arun is a primary care provider, practicing in Family Medicine in Silver Spring, Maryland. Dr. Arun is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Sitosterolemia, Vitamin D Deficiency, High Cholesterol, and Glucocorticoid-Remediable Aldosteronism.

Sumana Kommana is an Ophthalmologist in Baltimore, Maryland. Dr. Kommana is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Cataract, Nearsightedness, Interstitial Keratitis, and Astigmatism. Dr. Kommana is currently accepting new patients.

Marjorie Warden is an Ophthalmologist in Baltimore, Maryland. Dr. Warden is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Cataract, Interstitial Keratitis, Chalazion, and Eyelid Bump. Dr. Warden is currently accepting new patients.

Kenneth Taubenslag is an Ophthalmologist in Baltimore, Maryland. Dr. Taubenslag is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Endophthalmitis, Neuroretinitis, Uveitis, Trabeculectomy, and Vitrectomy. Dr. Taubenslag is currently accepting new patients.

Lisa Schocket is an Ophthalmologist in Baltimore, Maryland. Dr. Schocket is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). Her top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Schocket is currently accepting new patients.

George Agritellis is an Ophthalmologist in Baltimore, Maryland. Dr. Agritellis is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Cataract, Meibomianitis, Glaucoma, and Eyelid Bump. Dr. Agritellis is currently accepting new patients.

Jonathan Katz is an Ophthalmologist in Baltimore, Maryland. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of X-Linked Retinitis Pigmentosa (XLRP). His top areas of expertise are Glaucoma, Cataract, Ocular Hypertension (OHT), and Pigment-Dispersion Syndrome. Dr. Katz is currently accepting new patients.